에 대한 최신 뉴스 BrightView Hldgs (NYSE:BV) 주식

BrightView Hldgs

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature, and the Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

BrightView Holdings

BrightView Holdings Inc

HSBC BANK 21/05/25 WNT

HSBC BANK 19/05/25 WNT

HSBC BANK 24/04/25 WNT

HSBC BANK 09/04/25 WNT

BIOVAXYS TECHNOLOGY CORP by BioVaxys Technology Corp.

BioVaxys Technology Corp

BATM ADVANCED COMM by BATM Advanced Communications GBP

BATM Advanced Communications Ltd

MARIE BRIZARD W & S ORD by MARIE BRIZARD WINE & SPIRITS SA

Beaver Coal Ltd

BV Financial Inc

Bluegreen Vacations Holdings Corp Com Cl A

Bluegreen Vacations Holding Corp Class B

Vistry Group PLC

VISTRY GROUP PLC UNSP/ADR by VISTRY GROUP PLC.

BREVILLE GROUP LTD by Breville Group Ltd.

Breville Group Ltd

BREVILLE GRP UNSP/ADR by Breville Group Ltd.

Bold Ventures Inc

Compañía de Minas Buenaventura SAA

BAVARIAN NORDIC A S by Bavarian Nordic A/S

Bavarian Nordic AS

BAVARIAN NORDIC ORD

BevCanna Enterprises Inc

BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S

BUENAVENTURA ADR REP 1 ORD

Bureau Veritas SA

Bioventus Inc

BRAVURA SOLUTIONS LTD by Bravura Solutions Ltd.

Bravura Solutions Ltd

Iconic Minerals Ltd Ordinary Shares - New

BRAVATEK SOLUTIONS by Bravatek Solutions, Inc.

Bravatek Solutions Inc

BIVICTRIX THERAPEUTICS PL by BIVICTRIX THERAPEUTICS PLC

BiVictriX Therapeutics PLC

BUREAU VERITAS SA UNS/ADR by Bureau Veritas SA

Morgan Stanley analyst Toni Kaplan initiates coverage on BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Equal-Weight rating and announces Price Target of $16.

News

Price Target

Initiation

Analyst Ratings

Morgan Stanley Initiates Coverage On BrightView Hldgs with Equal-Weight Rating, Announces Price Target of $16

WIIM

BrightView Holdings shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target on the stock from $13 to $17.

In the preceding three months, 6 analysts have released ratings for BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>), presenting a wide array of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $15.88, a high estimate of $18.00, and a low estimate of $11.30. This current average has increased by 24.06% from the previous average price target of $12.80. 
<img src="https://www.benzinga.com/files/images/story/2024/1724263247_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of BrightView Hldgs among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Stephanie Moore</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$17.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$14.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>George Kelly</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$11.30</td>
<td>$10.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Jeffrey Stevenson</td>
<td>Loop Capital</td>
<td>Announces</td>
<td>Buy</td>
<td>$18.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to BrightView Hldgs. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of BrightView Hldgs compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of BrightView Hldgs's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into BrightView Hldgs's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BV/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on BrightView Hldgs analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know BrightView Hldgs Better</h2>
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature, and the Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
<h3>BrightView Hldgs: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining BrightView Hldgs's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -3.55% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: BrightView Hldgs's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 1.26%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.74%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.28%, the company showcases effective utilization of assets.
Debt Management: BrightView Hldgs's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.71.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In-Depth Examination Of 6 Analyst Recommendations For BrightView Hldgs

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page.</a>
<ul>
<li>Jefferies raised the price target for BrightView Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) from $13 to $17. Jefferies analyst Stephanie Moore upgraded the stock from Hold to Buy. BrightView shares fell 2.9% to close at $14.54 on Tuesday. <a href="https://www.benzinga.com/quote/BV/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo cut the price target for Sonoco Products Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SON#NYSE">SON</a>) from $54 to $52. Wells Fargo analyst Gabe Hajde downgraded the stock from Equal-Weight to Underweight. Sonoco shares fell 0.5% to close at $50.57 on Tuesday. <a href="https://www.benzinga.com/quote/SON/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup raised Texas Instruments Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) price target from $200 to $235. Citigroup analyst Christopher Danely upgraded the stock from Neutral to Buy. Texas Instruments shares gained 0.9% to close at $202.54 on Tuesday. <a href="https://www.benzinga.com/quote/TXN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird boosted the price target for Medtronic plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) from $82 to $90. Baird analyst David Rescott maintained a Neutral rating. Medtronic shares gained 0.7% to close at $85.38 on Tuesday. <a href="https://www.benzinga.com/quote/MDT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley raised Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) price target from $98 to $100. Morgan Stanley analyst Andrew Percoco maintained an Equal-Weight rating. Enphase Energy shares fell 2.3% to close at $116.98 on Tuesday. <a href="https://www.benzinga.com/quote/ENPH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities slashed Cogent Communications Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCOI#NASDAQ">CCOI</a>) price target from $75 to $65. B of A Securities analyst David Barden downgraded the stock from Neutral to Underperform. Cogent Communications shares fell 1.4% to close at $74.73 on Tuesday. <a href="https://www.benzinga.com/quote/CCOI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho increased the price target for Corning Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) from $44 to $47. Mizuho analyst John Roberts upgraded the stock from Neutral to Outperform. Corning shares gained 0.3% to close at $40.73 on Tuesday. <a href="https://www.benzinga.com/quote/GLW/analyst-ratings">See how other analysts view this stock.</a></li>
<li>CLSA cut Vipshop Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) price target from $15.8 to $12. CLSA analyst Leo You downgraded the stock from Outperform to Hold. Vipshop shares dipped 17.6% to close at $11.56 on Tuesday. <a href="https://www.benzinga.com/quote/VIPS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Raymond James boosted Agree Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>) price target from $70 to $81. Raymond James analyst RJ Milligan maintained a Strong Buy rating. Agree Realty shares fell 0.2% to close at $72.17 on Tuesday. <a href="https://www.benzinga.com/quote/ADC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Maxim Group slashed Dermata Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRMA#NASDAQ">DRMA</a>) price target from $10 to $6. Maxim Group analyst Anthony Vendetti maintained a Buy rating. Dermata Therapeutics shares fell 6.1% to close at $2.02 on Tuesday. <a href="https://www.benzinga.com/quote/DRMA/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying TXN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="514" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21085756/image-182-1024x514.png" alt="" class="wp-image-506185" style="width:542px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21085756/image-182-1024x514.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21085756/image-182-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21085756/image-182-768x386.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21085756/image-182.png 1346w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40478428/s-p-500-nasdaq-fall-after-8-session-winning-streak-ahead-of-powells-comments-and-fed-meeting-outcom">S&amp;P 500, Nasdaq Fall After 8-Session Winning Streak Ahead Of Powell&#8217;s Comments And FOMC Minutes: Fear &amp; Greed Index In &#8216;Neutral&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

CCOI

DRMA

ENPH

VIPS

Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday

Jefferies analyst Stephanie Moore upgrades BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) from Hold to Buy and raises the price target from $13 to $17.

Upgrades

Jefferies Upgrades BrightView Hldgs to Buy, Raises Price Target to $17

JP Morgan analyst Andrew Steinerman maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Underweight and raises the price target from $11 to $14.

JP Morgan Maintains Underweight on BrightView Hldgs, Raises Price Target to $14

Goldman Sachs analyst George Kelly maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Sell and raises the price target from $10 to $11.3.

Goldman Sachs Maintains Sell on BrightView Hldgs, Raises Price Target to $11.3

Baird analyst Andrew Wittmann maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Outperform and raises the price target from $17 to $18.

Baird Maintains Outperform on BrightView Hldgs, Raises Price Target to $18

Guidance

BrightView Sees Q3 2024 Free Cash Flow $65M-$80M Vs $55M-$75M Prior

BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) reported quarterly earnings of $0.32 per share which met the analyst consensus estimate. The company reported quarterly sales of $738.80 million which missed the analyst consensus estimate of $741.00 million by 0.30 percent. This is a 3.55 percent decrease over sales of $766.00 million the same period last year.

Earnings

Earnings Misses

BrightView Hldgs Q3 2024 Adj. EPS $0.32, Inline, Sales $738.80M Miss $741.00M Estimate

Baird analyst Andrew Wittmann upgrades BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) from Neutral to Outperform and raises the price target from $13 to $17.

Baird Upgrades BrightView Hldgs to Outperform, Raises Price Target to $17

Loop Capital analyst Jeffrey Stevenson initiates coverage on BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Buy rating and announces Price Target of $18.

Loop Capital Initiates Coverage On BrightView Hldgs with Buy Rating, Announces Price Target of $18

Offerings

BrightView Announces Pricing Of Secondary Offering Of 17.5M Shares; No Shares Sold By BrightView; Selling Stockholder To Receive All Proceeds From Offering

BrightView Holdings shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results. Also, Baird maintained a Neutral rating on the stock and raised its price target from $8.5 to $13.

Baird analyst Andrew Wittmann maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Neutral and raises the price target from $8.5 to $13.

Baird Maintains Neutral on BrightView Hldgs, Raises Price Target to $13

BrightView Holdings Cuts FY24 Revenue From $2.825B-$2.975B To $2.74B-$2.80B Vs $2.844B Est.

BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.07 by 57.14 percent. This is a 257.14 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $672.900 million which missed the analyst consensus estimate of $683.797 million by 1.59 percent. This is a 3.46 percent increase over sales of $650.400 million the same period last year.

Earnings Beats

BrightView Hldgs Q2 2024 Adj EPS $0.11 Beats $0.07 Estimate, Sales $672.900M Miss $683.797M Estimate

Brightview Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bv#NYSE">BV</a>) shares were down on Thursday, after adding <a href="https://www.benzinga.com/quote/BV">more than 22% over the past month</a>.
Although the company&rsquo;s efforts to weed out unprofitable and low-margin contracts will help margin recovery, its EBITDA margins could remain below the pre-COVID pandemic levels over the next three years, according to Goldman Sachs.
The Brightview Holdings Analyst: George Tong downgraded the rating for Brightview Holdings from Neutral to Sell, while raising the price target from $8 to $10.
The Brightview Holdings Thesis: The company&rsquo;s strategy to exit uneconomical contracts will adversely impact revenues in the near-to-medium term in its landscape maintenance business, which currently contributes around two-thirds of total revenue, Tong said in the downgrade note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
&ldquo;The company&rsquo;s decision to manage down its subcontractor business, which operates at lower margins, also creates headwinds to landscape maintenance revenue trends, in our view,&rdquo; the analyst wrote.
&ldquo;Further, we believe a warm 2023-2024 winter season, which represented the warmest winter on record in the US and the third warmest February in 130 years, will cause a shortfall in BV&rsquo;s snow removal revenue in F2Q relative to consensus and management&rsquo;s guidance,&rdquo; he added.
BV Price Action: Shares of Brightview Holdings had declined by 1.89% to $11.95&nbsp;at the time of publication on Thursday.
Read Next:&nbsp;<a href="https://www.benzinga.com/m-a/24/04/38092495/hubspot-stock-jumps-as-alphabet-considers-acquisition-offer-the-details">HubSpot Stock Jumps As Alphabet Considers Acquisition Offer: The Details</a>
Photo: Shutterstock

Analyst Color

Short Ideas

Downgrades

Small Cap

Movers

Brightview Holdings' Margin Strategy Hints At Strong Revenue Headwinds Ahead, Says Bearish Analyst

BrightView Holdings shares are trading lower after Goldman Sachs downgraded the stock from Neutral to Sell but raised its price target from $8 to $10.

Goldman Sachs analyst George Kelly downgrades BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) from Neutral to Sell and raises the price target from $8 to $10.

Goldman Sachs Downgrades BrightView Hldgs to Sell, Raises Price Target to $10

Goldman Sachs analyst George Tong reiterated a Sell rating on BrightView Holdings (BV – Research Report) today. The company's shares closed today a...

Goldman Sachs Sticks to Their Sell Rating for BrightView Holdings (BV)

BrightView Holdings, Inc. 2024 Q3 - Results - Earnings Call Presentation

BrightView Holdings, Inc. (BV) Q3 2024 Earnings Call Transcript

In a report released today, Stephanie Moore from Jefferies upgraded BrightView Holdings (BV – Research Report) to a Buy, with a price target of $17...

Optimistic Outlook: BrightView Holdings Set for Growth and Margin Expansion

Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on BrightView Holdings (BV – Research Report) and Reece Limite...

Analysts Offer Insights on Industrial Goods Companies: BrightView Holdings (BV) and Reece Limited (OtherREECF)

Craig-Hallum analyst Greg Palm maintained a Buy rating on BrightView Holdings (BV – Research Report) today. The company's shares closed yesterday a...

Craig-Hallum Sticks to Its Buy Rating for BrightView Holdings (BV)

Toni Kaplan, an analyst from Morgan Stanley, has initiated a new Hold rating on BrightView Holdings (BV). Toni Kaplan has given his Hold rating due...

BrightView Holdings: A Hold Rating Amidst Strategic Turnaround and Balanced Valuation

BrightView Blossoms With New Strategy And M&A Plans (Rating Upgrade)

Craig-Hallum Sticks to Their Buy Rating for BrightView Holdings (BV)

In a report released today, Greg Palm from Craig-Hallum maintained a Buy rating on BrightView Holdings (BV – Research Report). The company's shares...

Craig-Hallum Remains a Buy on BrightView Holdings (BV)

REECF

Press Releases

BrightView Transforms Historic Rickwood Field for MLB Special Game

BrightView Declares Cash Dividend Payment on Preferred Stock

BrightView Announces Increase and Extension of Receivables Financing Facility

BrightView to Participate in Upcoming CJS Securities Investor Conference

BrightView Holdings, Inc. Announces Third Quarter Fiscal Year 2024 Earnings Release Date, Conference Call and Webcast

BrightView Reports Third Quarter Earnings With Record EBITDA; Reaffirms Midpoint of Full Year Revenue, EBITDA, and Margin Guidance, and Raises Free Cash Flow Guidance

BrightView Empowers 21,000 Team Members with Pink Hats in Support of Breast Cancer Awareness Month

BrightView Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2024 Earnings Release Date, Conference Call and Webcast

Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

AZTA

LVWR

ABM Indus

Ambipar Emergency Response Class A Ordinary Shares

Ambipar Emergency

Aqua Metals

Aris Water Solutions, Inc. Class A Common Stock

Aris Water Solutions

Mobile Infrastructure Corporation Common Stock

Mobile Infrastructure

CDT Environmental Technology Investment Holdings Limited - ordinary shares

CDT Environmental

CECO Environmental

Clean Harbors

Casella Waste Systems, Inc. - Class A Common Stock

Casella Waste Sys

ESGL Holdings Limited - Class A Ordinary Shares

ESGL Holdings

Fuel Tech

Li-Cycle Holdings

LanzaTech Global

Montrose Environmental Group, Inc. Common Stock

Montrose Environmental Gr

Enviri

Perma-Fix Environmental Services, Inc. - Common Stock

Perma-Fix Envirn Servs

Quest Resource Holding Corporation - Common Stock

Quest Resource Holding

Rollins

Republic Servs

Rentokil Initial plc American Depositary Shares (each representing five (5) Ordinary Shares)

Comments

BrightView Hldgs

뉴스

에 대한 최신 뉴스 BrightView Hldgs (NYSE:BV) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌